Seelos Therapeutics Faces Liquidation as Bankruptcy Filing Confirms Investor Wipeout

Seelos Therapeutics has initiated Chapter 11 bankruptcy proceedings, signaling a probable complete loss for shareholders. The biopharmaceutical firm’s voluntary petition, filed on November 16, 2024, in US Bankruptcy Court, reveals a staggering financial imbalance that leaves little hope for recovery. The company’s disclosed financial situation paints a dire picture. According to court documents, Seelos Therapeutics…

No Cookies | Daily Telegraph

Please note that by blocking any or all cookies you may not have access to certain features, content or personalization. For more information see our Cookie Policy. To enable cookies, follow the instructions for your browser below. Facebook App: Open links in External Browser There is a specific issue with the Facebook in-app browser intermittently…

No Cookies | The Courier Mail

Please note that by blocking any or all cookies you may not have access to certain features, content or personalization. For more information see our Cookie Policy. To enable cookies, follow the instructions for your browser below. Facebook App: Open links in External Browser There is a specific issue with the Facebook in-app browser intermittently…

No Cookies | Herald Sun

Please note that by blocking any or all cookies you may not have access to certain features, content or personalization. For more information see our Cookie Policy. To enable cookies, follow the instructions for your browser below. Facebook App: Open links in External Browser There is a specific issue with the Facebook in-app browser intermittently…

Powerlong Commercial Management Announces Liquidation Hearing Adjournment

Meet Your ETF AI Analyst The latest announcement is out from Powerlong Commercial Management Holdings Limited ( (HK:9909) ). Powerlong Commercial Management Holdings Limited announced that the hearing for the liquidation application against its direct holding company, Powerlong Real Estate (BVI) Holdings Limited, has been postponed to December 2025. This delay allows the company more…